Ash Stevens Inc., now part of Piramal Pharma Solutions is a fully integrated CDMO, offering comprehensive drug substance development and API manufacturing services to clients developing innovative small- molecule drugs. To date, the company has received thirteen U.S. FDA approvals, including four with FDA fast track designations. Ash Stevens supports all aspects of drug development and cGMP manufacturing from de novo process development to commercial API production. The companys state-of-the-art manufacturing facility, located in Riverview, Michigan, is FDA-registered and has the capacity to develop and manufacture APIs from grams to batch sizes of up to 250 kilograms.